Javier Egea

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 26

Top Topics

Inflammatory Response

Top Venues

Antioxidants (Basel, Switzerland)

British journal of pharmacology

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Alejandra Palomino-Antolín, Céline Decouty-Pérez, Víctor Farré-Alins, Paloma Narros-Fernández, Ana Belen Lopez-Rodriguez, María Álvarez-Rubal, Inés Valencia, Francisco López Muñoz, Eva Ramos, Antonio Cuadrado, Ana I Casas, Alejandro Romero Martínez, Javier Egea
Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4. Antioxidants (Basel, Switzerland) 12 (9) (2023)
Victoria Jiménez Carretero, Eva Ramos, Pedro Segura-Chama, Adan Hernández, Andrés M Baraibar, Iris Álvarez-Merz, Francisco López Muñoz, Javier Egea, José M Solís, Alejandro Romero Martínez, Jesús M Hernández-Guijo
Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging. Antioxidants (Basel, Switzerland) 12 (10) (2023)
Eva Ramos, Javier Egea, Francisco López Muñoz, Emilio Gil-Martín, Alejandro Romero Martínez
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review. Pharmaceutics 15 (6) (2023)
Eva Ramos, Emilio Gil-Martín, Cristóbal de Los Ríos, Javier Egea, Francisco López Muñoz, René Pita, Antonio Juberías, Juan José Torrado, Dolores Remedios Serrano, Russel Joseph Reiter, Alejandro Romero Martínez
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Eva Ramos, Javier Egea, Francisco López Muñoz, Emilio Gil-Martín, Alejandro Romero Martínez
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review. Pharmaceutics 15 (6) (2023)
Damiano Rocchi, Juan-Francisco González, Olmo Martín-Cámara, Maria Grazia Perrone, Morena Miciaccia, Antonio Scilimati, Celine Decouty-Pérez, Esther Parada, Javier Egea, José Carlos Menéndez
m -Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity. Molecules (Basel, Switzerland) 28 (14) (2023)
Eva Ramos, Emilio Gil-Martín, Cristóbal de Los Ríos, Javier Egea, Francisco López Muñoz, René Pita, Antonio Juberías, Juan José Torrado, Dolores Remedios Serrano, Russel Joseph Reiter, Alejandro Romero Martínez
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Eva Ramos, Emilio Gil-Martín, Cristóbal de Los Ríos, Javier Egea, Francisco López Muñoz, René Pita, Antonio Juberías, Juan José Torrado, Dolores Remedios Serrano, Russel Joseph Reiter, Alejandro Romero Martínez
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Paloma Narros-Fernández, Mourad Chioua, Sonia A Petcu, Daniel Diez-Iriepa, Laura Cerrada-Gálvez, Céline Decouty-Pérez, Alejandra Palomino-Antolín, Eva Ramos, Víctor Farré-Alins, Ana Belén López-Rodríguez, Alejandro Romero Martínez, José Marco-Contelles, Javier Egea
Synthesis and Pharmacological Evaluation of New N -Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat Gout. Journal of medicinal chemistry 65 (8) (2022)
Ana Belen Lopez-Rodriguez, Céline Decouty-Perez, Víctor Farré-Alins, Alejandra Palomino-Antolín, Paloma Narros-Fernández, Javier Egea
Activation of NLRP3 Is Required for a Functional and Beneficial Microglia Response after Brain Trauma. Pharmaceutics 14 (8) (2022)
Eva Ramos, Francisco López Muñoz, Emilio Gil-Martín, Javier Egea, Iris Álvarez-Merz, Sakshi Painuli, Prabhakar Semwal, Natália Cruz Martins, Jesús M Hernández-Guijo, Alejandro Romero Martínez
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants (Basel, Switzerland) 10 (7) (2021)
Alejandra Palomino-Antolin, Paloma Narros-Fernández, Víctor Farré-Alins, Javier Sevilla-Montero, Celine Decouty-Pérez, Ana Belen Lopez-Rodriguez, Nuria Fernández, Luis Monge, Ana I Casas, María José Calzada, Javier Egea
Time-dependent dual effect of NLRP3 inflammasome in brain ischemia. British journal of pharmacology (2021)
José M Alonso, Alejandro Escobar-Peso, Alejandra Palomino-Antolín, Daniel Diez-Iriepa, Mourad Chioua, Emma Martínez-Alonso, Isabel Iriepa, Javier Egea, Alberto Alcázar, José Marco-Contelles
Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Alejandro Romero Martínez, Eva Ramos, Francisco López Muñoz, Cristóbal de Los Ríos, Javier Egea, Emilio Gil-Martín, René Pita, Juan J Torrado, Dolores Remedios Serrano, Antonio Juberias
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? Diseases (Basel, Switzerland) 9 (2) (2021)
Víctor Farré-Alins, Alejandra Palomino-Antolín, Paloma Narros-Fernández, Ana Belen Lopez-Rodriguez, Céline Decouty-Perez, Alicia Muñoz-Montero, Jorge Zamorano-Fernández, Beatriz Mansilla-Fernández, Javier Giner-García, Pablo García-Feijoo, Miguel Sáez-Alegre, Alexis J Palpán-Flores, José María Roda-Frade, Cristina S Carabias, Juliana M Rosa, Belén Civantos-Martín, Santiago Yus-Teruel, Luis Gandía, Alfonso Lagares, Borja J Hernández-García, Javier Egea
Serum Amyloid A1/Toll-Like Receptor-4 Axis, an Important Link between Inflammation and Outcome of TBI Patients. Biomedicines 9 (6) (2021)
Francesco Calzaferri, Paloma Narros-Fernández, Ricardo de Pascual, Antonio M G de Diego, Annette Nicke, Javier Egea, Antonio G García, Cristóbal de Los Ríos
Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation. Journal of medicinal chemistry 64 (4) (2021)
Eva Ramos, Rocío Lajarín-Cuesta, Raquel L Arribas, Eva M García-Frutos, Laura González-Lafuente, Javier Egea, Cristóbal de Los Ríos, Alejandro Romero Martínez
In Silico Prediction of the Toxic Potential of Neuroprotective Bifunctional Molecules Based on Chiral N-Propargyl-1,2-amino Alcohol Derivatives. Chemical research in toxicology 34 (5) (2021)
Juliana M Rosa, Víctor Farré-Alins, María Cristina Ortega, Marta Navarrete, Ana Belen Lopez-Rodriguez, Alejandra Palomino-Antolín, Elena Fernández-López, Virginia Vila-Del Sol, Céline Decouty, Paloma Narros-Fernández, Diego Clemente, Javier Egea
TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury. British journal of pharmacology 178 (17) (2021)
Víctor Farré-Alins, Paloma Narros-Fernández, Alejandra Palomino-Antolín, Céline Decouty-Pérez, Ana Belen Lopez-Rodriguez, Esther Parada, Alicia Muñoz-Montero, Vanessa Gómez-Rangel, Francisco López Muñoz, Eva Ramos, Águeda González-Rodríguez, Luis Gandía, Alejandro Romero Martínez, Javier Egea
Melatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux. Antioxidants (Basel, Switzerland) 9 (12) (2020)
Melania Guerrero-Hue, Sandra Rayego-Mateos, Cristina Vázquez-Carballo, Alejandra Palomino-Antolín, Cristina García-Caballero, Lucas Opazo-Rios, José Luis Morgado-Pascual, Carmen Herencia, Sebastián Mas, Alberto Ortiz Arduan, Alfonso Rubio-Navarro, Javier Egea, José Manuel Villalba, Jesús Egido, Juan Antonio Moreno
Protective Role of Nrf2 in Renal Disease. Antioxidants (Basel, Switzerland) 10 (1) (2020)
Pablo Hernansanz-Agustín, Carmen Choya-Foces, Susana Carregal-Romero, Elena Ramos, Tamara Oliva, Tamara Villa-Piña, Laura Moreno, Alicia Izquierdo-Álvarez, J Daniel Cabrera-García, Ana Cortés, Ana Victoria Lechuga-Vieco, Pooja Jadiya, Elisa Navarro, Esther Parada, Alejandra Palomino-Antolín, Daniel Tello, Rebeca Acín-Pérez, Juan Carlos Rodríguez-Aguilera, Plácido Navas, Ángel Cogolludo, Ivan López-Montero, Adenike Adegbayi, Javier Egea, Manuela G López, John W Elrod, Jesús Ruíz-Cabello, Anna Bogdanova, José Antonio Enríquez, Antonio Martínez-Ruiz
Na+ controls hypoxic signalling by the mitochondrial respiratory chain. Nature 586 (7828) (2020)
Eva Ramos, Alejandra Palomino-Antolín, Manuela Bartolini, Isabel Iriepa, Ignacio Moraleda, Daniel Diez-Iriepa, Abdelouahid Samadi, Carol V Cortina, Mourad Chioua, Javier Egea, Alejandro Romero Martínez, José Marco-Contelles
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy. Molecules (Basel, Switzerland) 24 (8) (2019)
Esther Parada, Ana I Casas, Alejandra Palomino-Antolin, Vanessa Gómez-Rangel, Alfonso Rubio-Navarro, Victor Farré-Alins, Paloma Narros-Fernandez, Melania Guerrero-Hue, Juan Antonio Moreno, Juliana M Rosa, José M Roda, Borja J Hernández-García, Javier Egea
Early toll-like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro-inflammatory phenotype in rodent and human brain ischaemia models. British journal of pharmacology 176 (15) (2019)
Raquel L Arribas, Alejandro Romero, Javier Egea, Cristóbal de Los Ríos
Modulation of serine/threonine phosphatases by melatonin: therapeutic approaches in neurodegenerative diseases. British journal of pharmacology 175 (16) (2018)
Alejandro Romero, Esther Parada, Laura González-Lafuente, Victor Farré-Alins, Eva Ramos, Ramón Cacabelos, Javier Egea
Neuroprotective effects of E-PodoFavalin-15999 (Atremorine®). CNS neuroscience & therapeutics 23 (5) (2017)
Óscar M Bautista-Aguilera, Stefanie Hagenow, Alejandra Palomino-Antolin, Víctor Farré-Alins, Lhassane Ismaili, Pierre-Louis Joffrin, M Luisa Jimeno, Ondrej Soukup, Jana Janočková, Lena Kalinowsky, Ewgenij Proschak, Isabel Iriepa, Ignacio Moraleda, Johannes S Schwed, Alejandro Romero Martínez, Francisco López-Muñoz, Mourad Chioua, Javier Egea, Rona R Ramsay, José Marco-Contelles, Holger Stark
Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3 R Antagonism for Neurodegenerative Diseases. Angewandte Chemie (International ed. in English) 56 (41) (2017)